Evidence map›Paper›PMID 39168884›Full record

ArticleClinical and experimental nephrology2025

Recipients of public assistance with advanced chronic kidney disease: insights into receiving a presentation of kidney replacement therapy options and polypharmacy from Japanese investigators with innovative network about kidney disease study.

Yoshihiro Nakamura, Sho Sasaki, Takahiro Imaizumi, Hiroki Nishiwaki, Minoru Murakami, Masahiko Yazawa, Yoshihiko Raita, Hiroo Kawarazaki, Hideaki Shimizu, Yosuke Saka and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yoshihiro Nakamura *Department of Nephrology and Rheumatology, Chubu Rosai Hospital, Aichi, Japan.
Sho Sasaki *Section of Education for Clinical Research, Kyoto University Hospital, 54 Shogoinkawaracho, Sakyo-Ku, Kyoto, 606-8507, Japan. sasaki.sho.3f@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-6744-5931
Takahiro ImaizumiDepartment of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Hiroki NishiwakiDivision of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Minoru MurakamiDepartment of Nephrology, Saku Central Hospital, Nagano, Japan.
Masahiko YazawaDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Yoshihiko RaitaDepartment of Nephrology, Okinawa Chubu Hospital, Okinawa, Japan.
Hiroo KawarazakiDepartment of Nephrology, Inagi Municipal Hospital, Tokyo, Japan.
Hideaki ShimizuDepartment of Nephrology, Daido Hospital, Aichi, Japan.
Yosuke SakaDepartment of Nephrology, Kasugai Municipal Hospital, Aichi, Japan.
Naoho TakizawaDepartment of Nephrology and Rheumatology, Chubu Rosai Hospital, Aichi, Japan.
Yoshiro FujitaDepartment of Nephrology and Rheumatology, Chubu Rosai Hospital, Aichi, Japan.
Japanese investigators with Innovative Network for Kidney Disease: JOINT-KD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe characteristics of patients with advanced chronic kidney disease (CKD) who are recipients of public assistance in Japan, and the adequacy of their medical care have not been reported previously.

methodsThe records of patients with CKD stage G5 who visited nine facilities in Japan from April to June 2013 were retrospectively reviewed to compare the characteristics and care of recipients of public assistance with those of non-recipients. Receiving a presentation of kidney replacement therapy (KRT) options and polypharmacy were used as indicators of suboptimal medical care.

resultsOf the 592 patients included in this analysis (mean age, 69.6 years; male, 59.3%), 56 (9.5%) were recipients of public assistance and 536 (90.5%) were non-recipients of public assistance. The prevalence of diabetes mellitus, unmarried status, and living alone were higher in recipients of public assistance. In multivariable logistic regression analysis, compared with non-recipients of public assistance, recipients of public assistance were less likely to receive a presentation of KRT options (adjusted odds ratio [aOR], 0.31; 95% confidence interval [CI], 0.17-0.56), and were more likely to receive ≥ 10 (aOR, 1.92; 95% CI, 1.05-3.51), and ≥ 15 (aOR, 2.78; 95% CI, 1.23-6.26) types of medication.

conclusionsPatients with advanced CKD receiving public assistance were less likely to receive a presentation of KRT options and more likely to receive ≥ 10 and ≥ 15 types of medication, suggesting that recipients of public assistance are more likely to receive suboptimal medical care.

Indexed as

PolypharmacyRenal Insufficiency, ChronicRenal Replacement TherapyAgedAged, 80 and overFemaleHumansJapanLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioRetrospective StudiesAdvanced chronic kidney diseaseKidney replacement therapyPolypharmacyPublic assistanceSuboptimal medical care

Identifiers

PMID39168884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.